Amphiregulin Monoklonaler Antikörper
Amphiregulin Monoklonal Antikörper für WB, IHC, Indirect ELISA
Wirt / Isotyp
Maus / IgG1
Getestete Reaktivität
Hausschwein, human, Ratte
Anwendung
WB, IHC, Indirect ELISA
Konjugation
Unkonjugiert
CloneNo.
1A1G9
Kat-Nr. : 66433-1-PBS
Synonyme
Geprüfte Anwendungen
Produktinformation
66433-1-PBS bindet in WB, IHC, Indirect ELISA Amphiregulin und zeigt Reaktivität mit Hausschwein, human, Ratten
| Getestete Reaktivität | Hausschwein, human, Ratte |
| Wirt / Isotyp | Maus / IgG1 |
| Klonalität | Monoklonal |
| Typ | Antikörper |
| Immunogen | Amphiregulin fusion protein Ag8907 |
| Vollständiger Name | amphiregulin |
| Berechnetes Molekulargewicht | 252 aa, 28 kDa |
| Beobachtetes Molekulargewicht | 50 kDa, 37 kDa |
| GenBank-Zugangsnummer | BC009799 |
| Gene symbol | Amphiregulin/AREG |
| Gene ID (NCBI) | 374 |
| Konjugation | Unkonjugiert |
| Form | Liquid |
| Reinigungsmethode | Protein-G-Reinigung |
| Lagerungspuffer | PBS only |
| Lagerungsbedingungen | Store at -80°C. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
Amphiregulin (AREG) is one of the ligands of the epidermal growth factor receptor (EGFR). AREG plays a central role in mammary gland development and branching morphogenesis in organs and is expressed both in physiological and in cancerous tissues. The AREG protein is synthesized as a 252-amino acid transmembrane precursor, pro-AREG. At the plasma membrane, pro-AREG is subjected to sequential proteolytic cleavages within its ectodomain and is then released as the soluble AREG protein. Depending on the cell type and microenvironment, AREG can be produced in multiple cellular and mature forms using alternative pro-AREG cleavage sites and glycosylation motifs. Post-translastional modfications of 50-kDa pro-AREG produces a major soluble 43-kDa form, 28-, 26-, 16-kDa membrane anchored forms, and soluble 21-, 19-, and 9-kDa forms (PMID: 9642297).















